BIOFILCHEM2025-07-012025-09-30BIOFILCHEM2025-09-30BIOFILCHEM2025-07-012025-09-30CompositionOfBoardOfDirectors1BIOFILCHEM2025-09-30CompositionOfBoardOfDirectors1BIOFILCHEM2025-07-012025-09-30CompositionOfBoardOfDirectors2BIOFILCHEM2025-09-30CompositionOfBoardOfDirectors2BIOFILCHEM2025-07-012025-09-30CompositionOfBoardOfDirectors3BIOFILCHEM2025-09-30CompositionOfBoardOfDirectors3BIOFILCHEM2025-07-012025-09-30CompositionOfBoardOfDirectors4BIOFILCHEM2025-09-30CompositionOfBoardOfDirectors4BIOFILCHEM2025-07-012025-09-30CompositionOfBoardOfDirectors5BIOFILCHEM2025-09-30CompositionOfBoardOfDirectors5BIOFILCHEM2025-07-012025-09-30CompositionOfBoardOfDirectors6BIOFILCHEM2025-09-30CompositionOfBoardOfDirectors6BIOFILCHEM2025-07-012025-09-30CompositionOfCommittees14BIOFILCHEM2025-09-30CompositionOfCommittees14BIOFILCHEM2025-07-012025-09-30CompositionOfCommittees15BIOFILCHEM2025-09-30CompositionOfCommittees15BIOFILCHEM2025-07-012025-09-30CompositionOfCommittees16BIOFILCHEM2025-09-30CompositionOfCommittees16BIOFILCHEM2025-07-012025-09-30CompositionOfCommittees41BIOFILCHEM2025-09-30CompositionOfCommittees41BIOFILCHEM2025-07-012025-09-30CompositionOfCommittees42BIOFILCHEM2025-09-30CompositionOfCommittees42BIOFILCHEM2025-07-012025-09-30CompositionOfCommittees43BIOFILCHEM2025-09-30CompositionOfCommittees43BIOFILCHEM2025-07-012025-09-30CompositionOfCommittees68BIOFILCHEM2025-09-30CompositionOfCommittees68BIOFILCHEM2025-07-012025-09-30CompositionOfCommittees69BIOFILCHEM2025-09-30CompositionOfCommittees69BIOFILCHEM2025-07-012025-09-30CompositionOfCommittees70BIOFILCHEM2025-09-30CompositionOfCommittees70BIOFILCHEM2025-09-30MeetingOfBoardOfDirectors1BIOFILCHEM2025-07-012025-09-30MeetingOfBoardOfDirectors1BIOFILCHEM2025-09-30MeetingOfBoardOfDirectors2BIOFILCHEM2025-07-012025-09-30MeetingOfBoardOfDirectors2BIOFILCHEM2025-09-30MeetingOfBoardOfDirectors3BIOFILCHEM2025-07-012025-09-30MeetingOfBoardOfDirectors3BIOFILCHEM2025-09-30MeetingOfBoardOfDirectors4BIOFILCHEM2025-07-012025-09-30MeetingOfBoardOfDirectors4BIOFILCHEM2025-09-30MeetingOfBoardOfDirectors5BIOFILCHEM2025-07-012025-09-30MeetingOfBoardOfDirectors5BIOFILCHEM2025-07-012025-09-30MeetingOfCommittees1BIOFILCHEM2025-09-30MeetingOfCommittees1BIOFILCHEM2025-07-012025-09-30MeetingOfCommittees2BIOFILCHEM2025-09-30MeetingOfCommittees2BIOFILCHEM2025-07-012025-09-30MeetingOfCommittees3BIOFILCHEM2025-09-30MeetingOfCommittees3BIOFILCHEM2025-07-012025-09-30MeetingOfCommittees4BIOFILCHEM2025-09-30MeetingOfCommittees4BIOFILCHEM2025-07-012025-09-30MeetingOfCommittees5BIOFILCHEM2025-09-30MeetingOfCommittees5BIOFILCHEM2025-07-012025-09-30MeetingOfCommittees6BIOFILCHEM2025-09-30MeetingOfCommittees6BIOFILCHEM2025-06-30BIOFILCHEM2025-09-30ImpositionOfFineOrPenaltyDomain1BIOFILCHEM2025-09-30ImpositionOfFineOrPenaltyDomain2BIOFILCHEM2025-09-30ImpositionOfFineOrPenaltyDomain3BIOFILCHEM2025-09-30ImpositionOfFineOrPenaltyDomain4iso4217:INRxbrli:pure524396BIOFILCHEMNOTLISTEDINE829A01014BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED2025-04-012026-03-31Half Yearly2025-09-30EquitytruetruefalseNot Applicable since during the quarter company has not Acquired any share or voting rights in any unlisted company or other entity.truefalseNo such ongoing Tax Litigation or Dispute pending as on quarter ended 30th September, 2025.truefalseAny othertrueb00174OriginalBoard in their meeting held on 12th August, 2025 have considered and approved for Change in designation of Mr.Ketan Shah from whole time director to Chairman and Managing Director of the Company w.e.f. 12th August, 2025 and such appointment confirmed by members in their Annual General Meeting held on 27th September, 2025. Futher, Board in their meeting held on 23rd August, 2025 have considered and approved appointment of Mr. Smitesh Shah (DIN: 00326182), as an Additional Director under the category of Non- Executive Non-Independent Director w.e.f. 23rd August, 2025 and such appointment confirmed by members in their Annual General Meeting held on 27th September, 2025. truetrueMrKETAN SHAH******08818212Executive DirectorChairperson related to Promoter1961-07-21falseActiveNA2020-08-251000MrSATISH BEOHAR******09220291Non-Executive - Independent DirectorNot Applicable1969-12-24falseActiveNA2021-06-302021-06-3051.011120MrASHOK KUMAR RAMAWAT******08818263Non-Executive - Independent DirectorNot Applicable1952-09-27falseActiveNA2020-08-252025-08-2561.071120MrsGAYATRI PADIYAR******10260173Non-Executive - Independent DirectorNot Applicable1977-01-22falseActiveNA2023-08-142023-08-1425.181122MrMEET SHAH******06578351Non-Executive - Non Independent DirectorNot Applicable1992-04-04falseActiveNA2024-12-301000MrSMITESH SHAH******00326182Non-Executive - Non Independent DirectorNot Applicable1959-12-05falseActiveNA2025-08-232025-08-231.071000truetruetrueAudit Committee10260173GAYATRI PADIYARNon-Executive - Independent DirectorChairperson2024-04-01Audit Committee08818263ASHOK KUMAR RAMAWATNon-Executive - Independent DirectorMember2020-08-25Audit Committee09220291SATISH BEOHARNon-Executive - Independent DirectorMember2021-06-30Nomination and remuneration committee10260173GAYATRI PADIYARNon-Executive - Independent DirectorChairperson2024-04-01Nomination and remuneration committee08818263ASHOK KUMAR RAMAWATNon-Executive - Independent DirectorMember2020-08-25Nomination and remuneration committee09220291SATISH BEOHARNon-Executive - Independent DirectorMember2021-06-30Stakeholders Relationship Committee10260173GAYATRI PADIYARNon-Executive - Independent DirectorChairperson2024-04-01Stakeholders Relationship Committee08818263ASHOK KUMAR RAMAWATNon-Executive - Independent DirectorMember2020-08-25Stakeholders Relationship Committee09220291SATISH BEOHARNon-Executive - Independent DirectorMember2021-06-302025-04-19true5532025-05-3040true5532025-08-0465true5532025-08-127true5532025-08-2310true553Audit Committee2025-05-30true3330Audit Committee2025-08-0465true3330Audit Committee2025-08-127true3330Nomination and remuneration committee2025-04-19true3330Nomination and remuneration committee2025-08-12114true3330Nomination and remuneration committee2025-08-2310true3330truetruetruetrueNAtruetruetrueThe Company doesn't fall under the category of Top 1000 Listed Companies. Therefore, the Company is not required to constitute Risk Management Committee.Apoorv JainCompany Secretary and Compliance OfficerYesYesYesYesYesYesYesYesThe Company does not have any material subsidiary company, therefore disclosure requirements regarding the secretarial audit report of material subsidiary in annual report is not applicable to the Company. Furthermore the Company does not fall under top one thousand listed entities based on market capitalization, hence business responsibility report is not applicable to the comapny.Mr. Apoorv JainCompany Secretary and Compliance OfficerfalseApoorv JainCompany Secretary and Compliance OfficerIndore2025-10-1700000National Stock Exchange of India LimitedSOP Fine Levied of Rs. 21240/- including GST @18% for 18 days of non compliance till quarter ended June 2025 for non Compliance of Regulation 6 (1) of SEBI (LODR) Regulation2025-08-21As per Exchange Communication SOP Fine of Rs. 21240/- including GST @18% imposed on company for Non-compliance with requirement to appoint a qualified company secretary as the compliance officer under Regulation 6(1) of SEBI (LODR) RegulationCompany has deposited SOP fine of Rs.21240/- including GST @18% dated 22.08.2025 into respective account of exchange. However there is no impact on the financials, operations, or other activities of the CompanyBSE LimitedSOP Fine Levied of Rs. 21240/- including GST @18% for 18 days of non compliance till quarter ended June 2025 for non Compliance of Regulation 6 (1) of SEBI (LODR) Regulation2025-08-21As per Exchange Communication SOP Fine of Rs. 21240/- including GST @18% imposed on company for Non-compliance with requirement to appoint a qualified company secretary as the compliance officer under Regulation 6(1) of SEBI (LODR) RegulationCompany has deposited SOP fine of Rs.21240/- including GST @18% dated 22.08.2025 into respective account of exchange. However there is no impact on the financials, operations, or other activities of the CompanyNational Stock Exchange of India LimitedSOP Fine Levied of Rs.112100/- including GST @18% for 19 days of non compliance till quarter ended June 2025 for non Compliance of Regulation 17 of SEBI (LODR) Regulation2025-08-29As per Exchange Communication SOP Fine of Rs. 112100/- including GST @18% imposed on company for Non-compliance with the requirements pertaining to the composition of the Board Regulation 17(1) of SEBI (LODR) RegulationCompany has filed its waiver Application dated 18th September, 2025 in the matter of penalty imposed by Exchange in respect of delay in compliance of Regulation 17(1) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. However there is no impact on the financials, operations, or other activities of the Company.BSE LimitedSOP Fine Levied of Rs.112100/- including GST @18% for 19 days of non compliance till quarter ended June 2025 for non Compliance of Regulation 17 of SEBI (LODR) Regulation2025-08-29As per Exchange Communication SOP Fine of Rs. 112100/- including GST @18% imposed on company for Non-compliance with the requirements pertaining to the composition of the Board Regulation 17(1) of SEBI (LODR) RegulationCompany has filed its waiver Application dated 18th September, 2025 in the matter of penalty imposed by Exchange in respect of delay in compliance of Regulation 17(1) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. However there is no impact on the financials, operations, or other activities of the Company.00000000Nil00Nil00Nil00Nil00Nil00Nil00Nil00Nil00All loans (or other form of debt), guarantees, comfort letters (by whatever name called) or securities in connection with any loan(s) (or other form of debt) given directly or indirectly by the listed entity to promoter(s), promoter group, director(s) (including their relatives), key managerial personnel (including their relatives) or any entity controlled by them are in the economic interest of the company.trueDuring the half year ended 30th September, 2025: a) No loan or any other form of debt has been advanced by the Company to the specified categories of entities in respect of whom disclosure is required. b) No guarantee/comfort letter has been provided by the Company in connection with any loan(s) or any other form of debt availed by the specified categories of entities in respect of whom disclosure is required. c) No security has been provided by the Company in connection with any loan(s) or any other form of debt availed by the specified categories of entities in respect of whom disclosure is required Pavan Singh RajputCFOIndore2025-10-17